160 related articles for article (PubMed ID: 31029736)
1. Disulfiram, an alcohol dependence therapy, can inhibit the in vitro growth of Francisella tularensis.
Hamblin KA; Flick-Smith H; Barnes KB; Pereira-Leal JB; Surkont J; Hampson R; Atkins HS; Harding SV
Int J Antimicrob Agents; 2019 Jul; 54(1):85-88. PubMed ID: 31029736
[TBL] [Abstract][Full Text] [Related]
2. The interaction of disulfiram and H
Read E; Milford J; Zhu J; Wu L; Bilodeau M; Yang G
Toxicol Appl Pharmacol; 2021 Sep; 426():115642. PubMed ID: 34242567
[TBL] [Abstract][Full Text] [Related]
3. Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase.
Skrott Z; Majera D; Gursky J; Buchtova T; Hajduch M; Mistrik M; Bartek J
Oncogene; 2019 Oct; 38(40):6711-6722. PubMed ID: 31391554
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of isolates of Francisella tularensis types A and B from North America.
Urich SK; Petersen JM
Antimicrob Agents Chemother; 2008 Jun; 52(6):2276-8. PubMed ID: 18411318
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of isolates of Francisella tularensis from Turkey.
Kiliç S; Celebi B; Acar B; Ataş M
Scand J Infect Dis; 2013 May; 45(5):337-41. PubMed ID: 23249114
[TBL] [Abstract][Full Text] [Related]
6. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques.
Grossman TH; Anderson MS; Christ D; Gooldy M; Henning LN; Heine HS; Kindt MV; Lin W; Siefkas-Patterson K; Radcliff AK; Tam VH; Sutcliffe JA
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559261
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis.
Johansson A; Urich SK; Chu MC; Sjöstedt A; Tärnvik A
Scand J Infect Dis; 2002; 34(5):327-30. PubMed ID: 12069013
[TBL] [Abstract][Full Text] [Related]
8. A Bioluminescent Francisella tularensis SCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of Tularemia.
Hall CA; Flick-Smith HC; Harding SV; Atkins HS; Titball RW
Antimicrob Agents Chemother; 2016 Dec; 60(12):7206-7215. PubMed ID: 27671061
[TBL] [Abstract][Full Text] [Related]
9. Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain.
Aperis G; Fuchs BB; Anderson CA; Warner JE; Calderwood SB; Mylonakis E
Microbes Infect; 2007 May; 9(6):729-34. PubMed ID: 17400503
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
Caspar Y; Hennebique A; Maurin M
J Antimicrob Chemother; 2018 Mar; 73(3):687-691. PubMed ID: 29253157
[TBL] [Abstract][Full Text] [Related]
11. Complement C3 as a Prompt for Human Macrophage Death during Infection with Francisella tularensis Strain SCHU S4.
Brock SR; Parmely MJ
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28739830
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of Aldehyde Dehydrogenase by Disulfiram in the Presence and Absence of Lipoic Acid or Dihydrolipoic Acid: An in Vitro Study.
Bilska-Wilkosz A; Górny M; Iciek M
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31426424
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Susceptibility of Francisella tularensis Isolates in the United States, 2009-2018.
Choat J; Young J; Petersen JM; Dietrich EA
Clin Infect Dis; 2024 Jan; 78(Suppl 1):S4-S6. PubMed ID: 38294116
[TBL] [Abstract][Full Text] [Related]
15. Gallium Potentiates the Antibacterial Effect of Gentamicin against Francisella tularensis.
Lindgren H; Sjöstedt A
Antimicrob Agents Chemother; 2016 Jan; 60(1):288-95. PubMed ID: 26503658
[TBL] [Abstract][Full Text] [Related]
16. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells.
Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312
[TBL] [Abstract][Full Text] [Related]
17. Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors.
Choi SA; Choi JW; Wang KC; Phi JH; Lee JY; Park KD; Eum D; Park SH; Kim IH; Kim SK
Neuro Oncol; 2015 Jun; 17(6):810-21. PubMed ID: 25378634
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a Francisella tularensis-Caenorhabditis elegans Pathosystem for the Evaluation of Therapeutic Compounds.
Jayamani E; Tharmalingam N; Rajamuthiah R; Coleman JJ; Kim W; Okoli I; Hernandez AM; Lee K; Nau GJ; Ausubel FM; Mylonakis E
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652232
[No Abstract] [Full Text] [Related]
19. Rapid countermeasure discovery against Francisella tularensis based on a metabolic network reconstruction.
Chaudhury S; Abdulhameed MD; Singh N; Tawa GJ; D'haeseleer PM; Zemla AT; Navid A; Zhou CE; Franklin MC; Cheung J; Rudolph MJ; Love J; Graf JF; Rozak DA; Dankmeyer JL; Amemiya K; Daefler S; Wallqvist A
PLoS One; 2013; 8(5):e63369. PubMed ID: 23704901
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological exploitation of an off-target antibacterial effect of the cyclooxygenase-2 inhibitor celecoxib against Francisella tularensis.
Chiu HC; Yang J; Soni S; Kulp SK; Gunn JS; Schlesinger LS; Chen CS
Antimicrob Agents Chemother; 2009 Jul; 53(7):2998-3002. PubMed ID: 19398640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
